Minimal change-like glomerular alterations induced by a human plasma factor

Nephron

Volumn 74, Issue 3, 1996, Pages 586-593

  Cheung, Po Kam ^a   Klok, Pieter A ^a   Bokker, Winston W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Glomerular ecto ATPase; Minimal change nephrotic syndrome; Permeability factor; Selective permeability

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALBUMIN; IMMUNOGLOBULIN G; POLYANION; PROTEIN; PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MINIMAL CHANGE GLOMERULONEPHRITIS; NONHUMAN; PATHOGENESIS; PERFUSION; PERMEABILITY; PLASMA FACTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; SPECTROPHOTOMETRY;

EID: 0029905720     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189457     Document Type: Article

References (46)

1. Schnaper HW, Robson AM: Nephrotic syndrome: Minimal change disease, focal glomerulosclerosis and related disorders: in Schrier RW, Gottschalk CM (eds): Diseases of the Kidney, ed 5, Boston, Little, Brown, 1993, pp 1731-1733.
2. Clark G, Barratt M: Minimal change nephrotic syndrome and focal segmental glomerulosclerosis; in Holliday MA, Barratt TM, Avner ED (eds): Pedriatic Nephrology, ed 3, Baltimore, William & Wilkins, 1994, pp 767-787.
3. Mallick NP: Epidemiology and natural course of idiopathic nephrotic syndrome, Clin Nephrol 1991;35(suppl 1):S3-S7.
4. Habib R, Churg J: Minimal change disease, mesangial proliferative glomerulonephritis and focal sclerosis: Individual entities or a spectrum of disease; in Nephrology I, New York, Springer, 1988, p 634.
5. Vernier RL: Primary (idiopathic) nephrotic syndrome; in Holliday MA, Barratt TM, Vernier RL (eds): Pediatric Nephrology, ed 2, Baltimore, Williams & Wilkins, 1987, pp445-456.
6. Blau EB, Haas JE: Glomerular sialic acid and proteinuria in human renal disease, Lab Invest 1973:28:477-482.
7. Bakker WW, Poclstra K, Hardonk MJ: Relevance of adenine nucleotidases in the glomerular filtration barrier, Nephron 1993:64:338-342.
8. Bakker WW, Poclstra K, Bailer JFW, Hardonk MJ: Demonstration of glomerular ATP/ADP-asc in the glomerular filtration barrier of the human kidney, Kidney Int 1990:38:361.
9. Shaloub RJ: Pathogenesis of lipoid nephrosis: A disorder of T-cell function, Lancet 1974;Vol ii: 556-559.
10. Tomizawa S, Maruyama K, Nagasawa N, Suzuki S, Kuroumc T: Studies of vascular permeability factor derived from T lymphocytes and inhibitory effect of plasma on its production in minimal change nephrotic syndrome, Nephron 1985:41:157-160.
11. Schnaper HW, Aune TM: Steroid-sensitive mechanism of soluble immune response suppressor production in steroid-responsive nephrotic syndrome, J Clin Invest 1987:79:257-264.
12. Inagc Z, Wada N, Kikkawa Y, Inami M, Hirosc H, Kitagawa T: Suppressor T-lymphocyte dysfunction in MCD: Role of the fL histamine receptor-bearing suppressor T-lvmphocytes, Clin Nephrol 1990:33:20-24.
13. Yokoyama H, Kida H, Abe T, Yoshimura M, Hattori N: Impaired immunoglobulin G production in minimal change nephrotic syndrome in adults, Clin Exp Immunol 1987;70: 110-115.
14. Taube D, Williams G: Pathogenesis of minimal change nephropathy: in Cameron.IS, Glassock RJ (eds): The Nephrotic Syndrome, New York, Dekker, 1988, p 193.
15. Schnaper HW: A regulatory system for soluble immune response suppressor production in steroid-responsive nephrotic syndrome, Kidney Int 1990:38:151-159.
16. Levin M, Smith C, Walters MDS, Gascoine P, Turner MW, Barrat TM: Steroid-responsive nephrotic syndrome, a generalized disorder of membrane-negative charge, Lancet 1985:Vol ii: 239-242.
17. Ghiggeri GM, Ginevri F, Candiano G, Olcg-gini R, Pcrfumo F, Qucirolo C, Gusmano R: Characterization of cationic albumin in minimal change nephropathy, Kidncv Int 1987:32: 547-553.
18. Lagruc G, Xheneumont S, Branellcc A, Hirbec G, Weil B: A vascular permeability factor elaborated from lymphocytes, Demonstration in patients with nephrotic syndrome, Biomedicine 1975;23:37-49.
19. Boulton-Jones JM, Tullock L, Dore B, Mclay A: Changes in the glomerular capillary wall induced by lymphocyte products and scrum of nephrotic patients, Clin Nephrol 1983:20:72-77.
20. Bakker WW, van der Laan SM, Vos JTWM, Hoedemaeker PJ: The glomerular polyanion of the rat kidney, I, Concanavalin-A-activated cells affect the glomerular polvanion in vitro, Nephron 1982;31:68-74.
21. Wilkinson A, Williams DG, Gillespie C, Hartley B: Nephrotic plasma increases proteinuria and reduced anionic sites on the glomerular basement membrane in vivo in NZW rabbits, Kidney Int 1986,29:295.
22. Thomson NM, Kraft N: Normal human scrum also contains the lymphotoxin found in minimal change nephropathy, Kidney Int 1987;31: 1186-1193.
23. Bakker WW, Beukhof JR, van Luijk WHJ, van der Hem GK: Vascular permeability increasing factor in IgA nephropathy, Clin Nephrol 1982: 18:165-267.
24. Savin VJ: Mechanisms of proteinuria in noninflammatory glomerular diseases, Am J Kidney Dis 1993;21:347-362.
25. Bakker WW, Baller JFW, van Luijk WHJ: A krallikrcin-likc molecule and plasma vasoactiv-itv in minimal change disease, Contrib Nephrol, Basel, Karger, 1988, vol 67, pp 31-36.
26. Bakker WW, van Luijk WHJ: Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome, Pcdiatr Nephrol 1989:3:341-349.
27. Bakker WW, Roskam G, Hardonk MJ, Vos JTWM, Blcumink E: The glomerular polyanion (GPA) of the rat kidney, III, Further characterization of a vaso-active serum factor which reduces GPA, Br J Exp Pathol 1985:66: 47-55.
28. Poelstra K, Hardonk MJ, Koudstaal J, Bakker WW: Intraglomerular platelet aggregation and experimental glomerulonephritis, Kidney Int 1990:37:1500-1508.
29. Van den Bom J, van den Heuvel LPWJ, Bakker MAH, Vecrkamp JH, Assmann KJM, Berden JHM: A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria, Kidney Int 1992;41:115-123.
30. Mohos SC, Skoza L: Histochemical demonstration and localization of sialoprotcins in the glomerulus, Exp Mol Pathol 1971:12:316-323.
31. Bailer JF: A modified cerium-based histochemical method for detection of experimentally-induced ecto-ATPase impairment in glomeruli of the rat kidney, J Histochem Cytochem 1993; 41:1105-1109.
32. Farquhar MG, Kanwar YS: Functional organization of the glomerulus: Presence of glycos-aminoglycans (proteoglycans) in the glomerular basement membrane; in Cummings NB, Michael AF, Wilson CB (eds): Immune Mechanisms in Renal Disease, New York, Plenum Medical, 1983, pp 1-33.
33. Bertani T, Poggi A, Pozzoni R, Dclaini F, Sac-chi G, Thoua Y, Mecca G, Remuzzi G, Donati MB: Adriamycin-induced nephrotic syndrome in rats: Sequence of pathologic events, Lab Invest 1982;46:16-23.
34. Caulfield JP, Farquhar MG: Distribution of anionic sites in glomerular basement membranes: Their possible role in filtration and attachment, Proc Natl Acad Sci USA 1976:73: 1646-1650.
35. Olson JL, Rcnnke HG, Vcnkatachalam MA: Alterations in the charge and size selectivity barrier of the glomerular filler in aminonuclco-side nephrosis in rats, Lablnvest 1981:44:271-279.
36. Yoshimura A, Ideura T, Iwasaki S, Koshikawa S: Aggravation of minimal change nephrotic syndrome by administration of human albumin, Clin Nephrol 1992:37:109-114.
37. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990:38: 384-394.
38. Bakker WW, Willink EJ, Donga J, Hulstaert CE, Hardonk MJ: Antithrombotic activity of glomerular adenosine diphosphatase in the glomerular basement membrane of the rat kidney, J Lab Clin Med 1987;109:171-177.
39. Poelstra K, Bailer JFW, Hardonk MJ, Bakker WW: Demonstration of antithrombotic activi-tv of glomerular adenosine diphosphatasc, Blood 1991;78:141-148.
40. Poelstra K, Hardonk MJ, Bakker WW: Adriamycin-induced decrease of ATPasc activity in the glomerular basement membrane of the rat kidney is mediated by oxygen free radical species: in Gublcr MC, Sternberg M (eds): Progress in Basement Membrane Research: Renal and Related Aspects in Health and Disease, London, Libbey, 1988, pp 259-264.
41. Bakker WW, Poelstra K, Barradas MA, Mik-hailidis DP: Platelets and cctonuclcotidascs, Platelets 1994;5:121-129.
42. Sterzel RB, Schulze-Lohoff E, Marx M: Cytokines and mesangial cells, Kidney Int 1993; 43(suppl 39):S26-S31.
43. Garin EH, Blanchard DK, Matsushima K, Dieu JY: 1L-8 production by peripheral blood mononuclear cells in nephrotic patients, Kidney Int 1994:45:1311-1317.
44. Cheung PK, Boes A, Dijkhuis FWJ, Klok PA, Bakker WW: Enhanced glomerular permeability and minimal change disease-like alterations of the rat kidney induced by a vasoactive human plasma factor (abstract), Kidney Int 1995; 47:1218.
45. Jensen T, Bjcrre-Knudsen J, Fcldt-Rasmusscn B, Dcckcrt T: Features of endothelial dysfunction in early diabetic nephropathy, Lancet 1989:Vol i:461-463.
46. Adler S: Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy, J Am Soc Nephrol 1994:5:1165-1172.